Eddie Joe Sullivan, CHIEF EXECUTIVE OFFICER, 10% Owner at SAB Biotherapeutics, Inc. (SABS), bought 14,000 shares at $0.74 ($10K) on 2022-09-07, disclosed to the SEC on 2022-09-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.